These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38420824)

  • 1. Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma.
    Acharya S; Thirunavukkarasu C
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):67. PubMed ID: 38420824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.
    Jia W; Xie G; Jia W
    Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):111-128. PubMed ID: 29018272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
    Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma.
    Song Y; Lau HC; Zhang X; Yu J
    Cancer Biol Med; 2023 Dec; 21(2):144-62. PubMed ID: 38148326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian's Knot.
    Aygün C; Tözün N
    J Gastrointest Cancer; 2021 Dec; 52(4):1309-1313. PubMed ID: 34750696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome in gastrointestinal cancer: a friend or foe?
    Liu Y; Baba Y; Ishimoto T; Gu X; Zhang J; Nomoto D; Okadome K; Baba H; Qiu P
    Int J Biol Sci; 2022; 18(10):4101-4117. PubMed ID: 35844804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
    Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
    Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
    Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Microbiome and Hepatocellular Carcinoma.
    Rattan P; Minacapelli CD; Rustgi V
    Liver Transpl; 2020 Oct; 26(10):1316-1327. PubMed ID: 32564483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.
    Ezzaidi N; Zhang X; Coker OO; Yu J
    Cancer Lett; 2019 Sep; 459():186-191. PubMed ID: 31185249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we change our microbiome to prevent colorectal cancer development?
    Manzat-Saplacan RM; Mircea PA; Balacescu L; Chira RI; Berindan-Neagoe I; Balacescu O
    Acta Oncol; 2015; 54(8):1085-95. PubMed ID: 26073561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Microbiome and Liver Cancer.
    Myojin Y; Greten TF
    Cancer J; 2023 Mar-Apr 01; 29(2):57-60. PubMed ID: 36957974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome in HCC - Mechanisms, diagnosis and therapy.
    Schwabe RF; Greten TF
    J Hepatol; 2020 Feb; 72(2):230-238. PubMed ID: 31954488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances.
    Kumar AR; Nair B; Kamath AJ; Nath LR; Calina D; Sharifi-Rad J
    Eur J Med Res; 2024 Oct; 29(1):485. PubMed ID: 39367507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions.
    Rajapakse J; Khatiwada S; Akon AC; Yu KL; Shen S; Zekry A
    Gut Microbes; 2023 Dec; 15(2):2240031. PubMed ID: 37615334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress of gut microbiota in hepatocellular carcinoma.
    Li K; Liu J; Qin X
    J Clin Lab Anal; 2022 Jul; 36(7):e24512. PubMed ID: 35719048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Microbiome and Hepatocellular Carcinoma.
    Akkız H
    J Gastrointest Cancer; 2021 Dec; 52(4):1314-1319. PubMed ID: 34870783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
    Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
    Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the microbiome in liver disease.
    Schöler D; Schnabl B
    Curr Opin Gastroenterol; 2024 May; 40(3):134-142. PubMed ID: 38362864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
    Ohtani N; Hara E
    Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.